Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Completion of Enrollment in NCX 470 Phase 2 Clinical Study with Top-Line Results on Track for Early 4Q 2019

July 16, 2019

View Press Release Corporate presentation Contact us
Previous